Northeast Warms Up As Life Science Capital/MRO Project Investment Nears $8 Billion
Attachment: US Northeastern Pharma & Biotech Projects, March 2015
SUGAR LAND--March 13, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Bone-chilling temperatures and unrelenting snowstorms have not prevented the U.S. Northeast region from being a favorite location for every sector of the life-science industry. The region, which includes Delaware, New Jersey, New York and Pennsylvania, has 145 active capital and MRO (maintenance) projects on the books, representing $7.6 billion in total investment value (TIV), according to Industrial Info's database.
Within this article: Details on life-science projects in the U.S. Northeast, including those from major companies like AstraZeneca (NYSE:AZN).
Other companies featured: Lockheed Martin (NYSE:LMT)
